Under the deal, $5.2 million will be channeled into strengthening Egypt's efforts to improve access to HIV and tuberculosis treatment services, while the remaining $5.9 million will be used for mitigating the negative impacts of COVID-19 on the country’s healthcare system.

The grant, which is being financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria, will support the country's National AIDS Programme and National Tuberculosis Control Programme for three years - from April 2022 to March 2025.

The grant will be disbersed in cooperation with the ministry's HIV and tuberculosis prevention programmes and civil society organisations in eight governorates.

This strategy focuses on intensifying efforts to reach the largest number of infected people, provide care to those infected, and ensure therapeutic adherence and the efficiency of health services.

Egypt’s National AIDS Programme was launched 35 years ago to combat HIV.

In December 2021, the health ministry announced that Egypt’s rate of HIV infection was significantly decreasing, with a prevalence rate of less than one percent.

The ministry has said Egypt is committed to the global strategy of combatting AIDS as a part of the Sustainable Development Goals (SDGs), which aims to end the AIDS epidemic by 2030.

The National Tuberculosis Control Programme provides early detection services for tuberculosis.

In March 2022, the ministry said that tuberculosis incidence rate in Egypt fell from 15,000 cases per 100,000 people in 2015 to only 11 cases in 2021.